References
- ZhuJLiuMLiuYZhangYYangBZhangWZoledronic acid regulates autophagy and induces apoptosis in colon cancer cell line CT26Biomed Res Int201720177203584720358629457036
- ArivazhaganRLeeJBayarsaikhanDMicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3LOncotarget2018945155516829435169
- PengQLinKChangTIdentification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysisOnco Targets Ther20181160961829430186
- QinYHuoZSongXChenXTianXWangXmir-106a regulates cell proliferation and apoptosis of colon cancer cells through targeting the PTEN/PI3K/AKT signaling pathwayOncol Lett20181533197320129435057
- SpalingerMRManziniRHeringLPTPN2 regulates inflammasome activation and controls onset of intestinal inflammation and colon cancerCell Rep20182271835184829444435
- WangNZhangYLiangHmicroRNA-598 inhibits cell proliferation and invasion of glioblastoma by directly targeting metastasis associated in colon cancer-1Oncol Res Epub2018214
- WuSSinghSVarneyMLKindleSSinghRKModulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasisCancer Med20121330631723342280
- MijatovicTMahieuTBruyèreCUNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancersNeoplasia200810657358618516294
- WangPYangXXuWLiKChuYXiongSIntegrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapyCancer Immunol Immunother201059111715172620706716
- RupertusKSinistraJScheuerCInteraction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancerClin Exp Metastasis201431444745924493023
- ZengYJLaiWWuHNeuroendocrine-like cells-derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancerOncotarget2016719273942740727034164
- GuoGPengYXiongBInvolvement of chemokine CXCL11 in the development of morphine tolerance in rats with cancer-induced bone painJ Neurochem2017141455356427926984
- KooYJKimTJMinKJSoKAJungUSHongJHCXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancerTumour Biol2017395101042831770622628488542
- ChangHShiYHTalafTKLinCAquaporin-8 mediates human esophageal cancer Eca-109 cell migration via the EGFR-Erk1/2 pathwayInt J Clin Exp Pathol20147117663767125550802
- KojimaSEnokidaHYoshinoHThe tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancerJ Hum Genet2014592788724284362
- DingCLuoJLiLGab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancerJ Exp Clin Cancer Res2016355526754532
- OrtegaCESeidnerYDominguezIMining CK2 in cancerPLoS One2014912e11560925541719
- SkrzypczakMGorycaKRubelTModeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliabilityPLoS One2010510e1309120957034
- HongYDowneyTEuKWKohPKCheahPYA ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeuticsClin Exp Metastasis2010272839020143136
- WangYChaiZWangMJinYYangALiMCOPB2 suppresses cell proliferation and induces cell cycle arrest in human colon cancer by regulating cell cycle-related proteinsExp Ther Med201815177778429399086
- WenYAXiongXZaytsevaYYDownregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancerCell Death Dis20189326529449559
- ZhaoPZhangZTNF-α promotes colon cancer cell migration and invasion by upregulating TROP-2Oncol Lett20181533820382729467899
- ZhongLHuotJSimardMJp38 activation induces production of miR-146a and miR-31 to repress E-selectin expression and inhibit transendothelial migration of colon cancer cellsSci Rep201881233429402939
- TokunagaRZhangWNaseemMCXCL9, CXCL10, CXCL11/ CXCR3 axis for immune activation – A target for novel cancer therapyCancer Treat Rev201863404729207310